TCG Crossover GP II, LLC 13D and 13G filings for LB Pharmaceuticals Inc Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | TCG Crossover GP II, LLC | 1,839,489 6.400% | 94,474 (+5.41%) | Filing |
| 2025-09-18 4:24 pm Purchase | 2025-09-12 | 13G | LB PHARMACEUTICALS INC LBRX | TCG Crossover GP II, LLC | 1,745,015 7.800% | 1,745,015 (New Position) | Filing |